Capital City Trust’s Amgen AMGN Stock Holding History

Capital City Trust’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.19M	Sell	6,237 -188	-3%	-$67K	0.5%	46
2025 Q4	$2.1M	Sell	6,425 -231	-3%	-$73.3K	0.47%	50
2025 Q3	$1.88M	Sell	6,656 -169	-2%	-$49K	0.46%	54
2025 Q2	$1.91M	Buy	6,825 +155	+2%	+$43.9K	0.49%	53
2025 Q1	$2.08M	Buy	6,670 +76	+1%	+$22.4K	0.57%	45
2024 Q4	$1.72M	Sell	6,594 -113	-2%	-$33.5K	0.43%	53
2024 Q3	$2.16M	Sell	6,707 -281	-4%	-$91.9K	0.54%	47
2024 Q2	$2.18M	Sell	6,988 -227	-3%	-$66.7K	0.59%	44
2024 Q1	$2.05M	Sell	7,215 -72	-1%	-$21.1K	0.57%	47
2023 Q4	$2.1M	Buy	7,287 +163	+2%	+$44.4K	0.62%	47
2023 Q3	$1.91M	Sell	7,124 -127	-2%	-$31.7K	0.63%	46
2023 Q2	$1.61M	Buy	7,251 +59	+0.8%	+$13.7K	0.5%	55
2023 Q1	$1.74M	Buy	7,192 +68	+1%	+$16.7K	0.55%	53
2022 Q4	$1.87M	Sell	7,124 -142	-2%	-$38.1K	0.62%	50
2022 Q3	$1.64M	Buy	7,266 +114	+2%	+$27.6K	0.57%	52
2022 Q2	$1.74M	Sell	7,152 -9	-0.1%	-$2.21K	0.57%	55
2022 Q1	$1.73M	Sell	7,161 -28	-0.4%	-$6.43K	0.5%	57
2021 Q4	$1.62M	Sell	7,189 -192	-3%	-$40.5K	0.46%	60
2021 Q3	$1.57M	Sell	7,381 -51	-0.7%	-$11.7K	0.49%	59
2021 Q2	$1.81M	Sell	7,432 -22	-0.3%	-$5.41K	0.55%	55
2021 Q1	$1.85M	Buy	7,454 +454	+6%	+$108K	0.59%	50
2020 Q4	$1.61M	Buy	7,000 +145	+2%	+$33.4K	0.56%	51
2020 Q3	$1.74M	Buy	6,855 +205	+3%	+$50.8K	0.64%	44
2020 Q2	$1.57M	Sell	6,650 -377	-5%	-$86K	0.6%	49
2020 Q1	$1.43K	Buy	7,027 +1,027	+17%	+$224K	0.64%	44
2019 Q4	$1.45M	Buy	6,000 +469	+8%	+$103K	0.55%	52
2019 Q3	$1.07M	Buy	5,531 +21	+0.4%	+$4.03K	0.47%	60
2019 Q2	$1.01M	Buy	5,510 +52	+1%	+$9.31K	0.42%	61
2019 Q1	$1.04M	Buy	5,458 +66	+1%	+$12.6K	0.44%	62
2018 Q4	$1.05M	Buy	5,392 +70	+1%	+$13.7K	0.48%	62
2018 Q3	$1.1M	Buy	5,322 +24	+0.5%	+$4.73K	0.44%	64
2018 Q2	$978K	Buy	5,298 +226	+4%	+$40K	0.42%	65
2018 Q1	$865K	Buy	5,072 +31	+0.6%	+$5.69K	0.37%	68
2017 Q4	$876	Buy	5,041 +246	+5%	+$43.5K	0.36%	72
2017 Q3	$826K	Hold	4,795	–	–	0.32%	71
2017 Q2	$826K	Buy	4,795 +240	+5%	+$39K	0.32%	71
2017 Q1	$747K	Buy	4,555 +340	+8%	+$56.5K	0.29%	74
2016 Q4	$616K	Buy	4,215 +155	+4%	+$23.3K	0.25%	76
2016 Q3	$677K	Buy	4,060 +240	+6%	+$40.6K	0.27%	74
2016 Q2	$581K	Buy	+3,820	New	+$594K	0.23%	74
2013 Q3	–	Sell	-50	Closed	-$5K	–	99
2013 Q2	$5K	Buy	+50	New	+$5.19K	﹤0.01%	200

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital City Trust's AMGN Position: Q1 2026 in Review

Capital City Trust reduced its Amgen (AMGN) stake by 2.9% in Q1 2026, selling an estimated $67K and leaving 6,237 shares worth $2.19M. The position accounts for 0.5% of the portfolio, ranked #46.

Capital City Trust first reported a position in AMGN in Q2 2013 and has held it in 41 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Capital City Trust held 6,237 shares of Amgen worth $2.19M as of Q1 2026.
Capital City Trust sold 188 Amgen shares in Q1 2026, an estimated $67K.
Amgen made up 0.5% of Capital City Trust's portfolio in Q1 2026, its #46 holding.
Capital City Trust first reported a position in Amgen in Q2 2013 and has held it in 41 quarters since.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Capital City Trust's 13F filing for Q1 2026, filed 1 May 2026.